Abstract
Direct-to-consumer (DTC) testing continues to be a subject of debate throughout the medical community. DTC testing may be viewed as expanding access to health care. Additionally, caution is needed in defining the role of DTC testing in the overall health care continuum of the consumer, particularly with limited provider resources. The recent COVID-19 pandemic resulted in a shift of consumer health care expectations and triggered providers to restructure their health care delivery services to create a more consolidated care model. There are several benefits from DTC testing that can help address this new restructure of health care, such as easy access to an available product and decreased person-to-person contact. However, there have been controversies regarding ethical considerations, appropriate specimen sampling, and evidence-based practices. This article provides an overview of DTC testing, advantages and concerns, considerations around infectious disease, and the potential role of the clinical laboratory to ensure safe and effective DTC testing services.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
